Share this article Share this article LUCID's technology platform unites music, AI and research in neuroscience to create personalized digital music therapy managed in real-time by therapists based on patient feedback VANCOUVER, BC, April 21, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ( "MINDCURE" or the "Company") a leader in advanced proprietary technology for psychedelic therapy, is pleased to announce a partnership with LUCID Inc. (" LUCID"). LUCID's mission is to help people optimize their mental wellness through music, and they will be designing custom psychedelic music experiences for iSTRYM. After announcing its data partnership with Speak Ai last week, MINDCURE continues to integrate world-class technologies into and create proprietary experiences within iSTRYM, its psychedelics digital therapeutics platform. LUCID's platform is a key differentiator for iSTRYM as therapists and patients seek out scientifically validated tools to enhance the effectiveness of psychedelic-assisted therapies. It will enable the therapist to alter the music within a therapy session based on real-time feedback and data collected from the patient, all within iSTRYM.